/

Companies / Thryv Therapeutics

Thryv Therapeutics

United States

Thryv Therapeutics is a clinical-stage biotechnology company advancing a portfolio of potent, selective inhibitors of serum and glucocorticoid-regulated kinase 1 (SGK1) as precision medicines for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.

Thryv Therapeutics, based in United States, has 1 investor on file, among them Amzak Health.

Investors

1 investor on file
InvestorEvidenceType
Amzak HealthPortfolio pageVenture capital

In the news

1 headline naming Thryv Therapeutics

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from Amzak Health

16 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

See Amzak Health's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Thryv Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Amzak Health adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/lqttrx.com/investors

# also
GET /v1/companies/lqttrx.com
GET /v1/companies/lqttrx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing